Evolva (EV-035 Series) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$29.7M
Evolva (EV-035 Series) General Information
Description
Provider of antibiotics. The business unit is an anti-bacterial programme which includes broad-spectrum antibiotic GC-072, which is being developed with US government bio-defense funding.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Primary Office
- Reinach
- Switzerland
Evolva (EV-035 Series) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Merger/Acquisition | 17-Dec-2014 | $29.7M | 000.00 | Completed | Product Development |
Evolva (EV-035 Series) Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Evolva | Corporation | Majority | 000 0000 | 000000 0 |